Successful Therapy With Anti Cd20 Monoclonal Antibody Rituximab In Patients With Acquired Hemophilia Against Factor Viii
35TH HEMOPHILIA SYMPOSIUM（2006）
摘要
- The therapy with Rituximab shows high response rates and appears to be effective in the elimination of inhibitors.
更多查看译文
关键词
Factor VIII, Anti CD20 Monoclonal Antibody, Immunomodulatory Treatment, Viii Inhibitor, Inhibitor Titer
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要